{"id":483886,"title":"Guidance Document Alternate Sample Retention Site Guidelines (GUI-0014) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T22:35:23.096000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/forms/alternate-sample-retention-site-guidelines-0014.html?wbdisable=true","snippet":"Guidance Document Alternate Sample Retention Site Guidelines (GUI-0014) This guidance has been archived. Updated content for GUI-0014 is included in: How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080) . This HTML document is not a…","rawSnapshotUrl":"/api/snapshots/raw/483886","browseUrl":"https://replay.healtharchive.ca/job-6/20260106223523/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/forms/alternate-sample-retention-site-guidelines-0014.html?wbdisable=true#ha_snapshot=483886","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}